Giant Biogene Holding stock | Growth outlook for 2026 & price target

Giant Biogene Holdin...

SEHK:2367

HK$ 29,02

+ HK$0,44 (1,54%)

29,02 HK$

+HK$0,44 (1,54%)

End-of-day quote: 03/27/2026

Giant Biogene Holding Stock Value

The current analyst rating for SEHK:2367 is Buy.

Buy

Giant Biogene Holding Company Info

EPS Growth 5Y

14,13%

Market Cap

HK$30,34 B

Long-Term Debt

HK$0,00 B

Annual earnings

03/26/2026 (A)

Dividend

HK$1,39

Dividend Yield

4,80%

Founded

2000

Industry

Health Care

Country

China

Website

Giant Biogene Holding

ISIN Number

KYG3887G1091

Website

http://www.xajuzi.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

HK$42,10

45.07%

Last Update: 03/26/2026

Analysts: 17

Highest Price Target HK$82,20

Average Price Target HK$42,10

Lowest Price Target HK$33,93

In the last five quarters, Giant Biogene Holding’s Price Target has fallen from HK$71,11 to HK$57,25 - a -19,49% decrease. Thridteen analysts predict that Giant Biogene Holding’s share price will increase in the coming year, reaching HK$42,10. This would represent an increase of 45,07%.

Top growth stocks in the health care sector (5Y.)

What does Giant Biogene Holding do?

Giant Biogene Holding Co., Ltd operates primarily in the biotechnology sector, focusing on the development, production, and marketing of a range of biotechnological products. Business Segments The company encompasses several business segments that reflect its diverse operations and market reach. The primary segments include biotechnology, healthcare products, agricultural biotechnology, and essential chemicals. Each segment plays a critical role in the overarching strategy of the company. Bio...

Giant Biogene Holding Co., Ltd operates primarily in the biotechnology sector, focusing on the development, production, and marketing of a range of biotechnological products.

Business Segments

The company encompasses several business segments that reflect its diverse operations and market reach. The primary segments include biotechnology, healthcare products, agricultural biotechnology, and essential chemicals. Each segment plays a critical role in the overarching strategy of the company.

Biotechnology: This segment focuses on innovative solutions derived from genetic research and development. It aims to enhance crop yield and resilience, while also addressing challenges such as pest resistance and environmental sustainability. The company conducts extensive research to ensure continuous improvement in its product offerings, which cater not only to agricultural needs but also to biopharmaceutical applications.

Healthcare Products: The healthcare division specializes in the development and marketing of healthcare-related biotechnology products. This extends beyond traditional pharmaceuticals, encompassing nutraceuticals and wellness products designed to promote health and well-being. The company employs stringent quality control and testing measures to ensure the safety and efficacy of its offerings in this segment.

Agricultural Biotechnology: This segment is pivotal in improving agricultural outputs. The company focuses on developing genetically modified organisms (GMOs) and other advanced agricultural technologies aimed at increasing food production efficiency. By partnering with farmers and agricultural institutions, the company facilitates the effective implementation of its biotechnological advancements.

Essential Chemicals: This segment comprises the production of essential chemicals used in various industries. The company applies innovative biotechnological processes to produce chemicals that are not only effective but also more environmentally friendly, contributing to sustainability in chemical manufacturing.

Business Strategy

The company adopts a multifaceted business strategy aimed at achieving sustained growth and market leadership. At the core of this strategy lies a commitment to research and development, which serves as the backbone for innovating new products and enhancing existing ones. The company recognizes the importance of staying at the forefront of technological advancements within the biotechnology sector. By investing heavily in R&D, it not only aims to improve product efficiency but also seeks to explore new applications and markets.

Moreover, the company's strategy emphasizes collaboration with various stakeholders, including academic institutions, research entities, and industry partners. These alliances facilitate knowledge sharing, resource pooling, and the acceleration of innovation cycles. By leveraging the expertise of external partners, the company enhances its capabilities to develop solutions that are tailored to meet the needs of its diverse customer base.

Additionally, the company places significant importance on regulatory compliance and quality assurance. It adheres to stringent industry standards and guidelines to ensure the safety and efficacy of its products. This focus on compliance fosters a strong reputation and builds customer trust, essential components for long-term success in the biotechnology sector.

Products and Services

The company offers a comprehensive array of products and services across its various business segments. The company's product offerings include:

Agricultural Products: This includes genetically modified seeds and biopesticides aimed at enhancing crop yields and reducing dependency on chemical pesticides. These innovations are designed to optimize agricultural outputs while being mindful of environmental impacts.

Healthcare Products: The healthcare division offers nutraceuticals and biopharmaceuticals that are designed to improve health outcomes. This includes dietary supplements and natural health products that leverage biotechnology principles for better efficacy.

Research and Development Services: The company provides R&D services that encompass custom biotechnological solutions tailored to the unique needs of clients, including product testing, formulation, and development assistance.

Consultancy Services: The company offers consultancy services that guide agricultural and healthcare entities in implementing biotechnology solutions effectively within their operational frameworks.

Training and Support: The company conducts training sessions and seminars aimed at educating clients and partners on the latest biotechnological advancements, instilling confidence in the use of its products.

Geographical Markets Served

The company primarily serves the Mainland China market, where it derives the majority of its revenue. The company maintains a strong foothold within the region, particularly in provinces known for agricultural activities. Despite a focused presence in China, the company is strategically positioned to explore expansion opportunities into international markets, aiming to leverage its innovative products and solutions globally.

Customers

The company serves a broad spectrum of customers, ranging from individual consumers to large agricultural enterprises and healthcare institutions. Key customers include agricultural producers who utilize the company's biotechnology products to enhance crop yields, as well as healthcare providers incorporating nutraceuticals into their wellness programs. The company prides itself on maintaining relationships with its clients, focusing on understanding their specific needs and providing tailored solutions.

Sales and Marketing

The company employs a multi-channel marketing strategy to promote its products and services. This includes direct sales, partnerships with distributors, and participation in trade shows and industry conferences. Additionally, the company utilizes online marketing and social media platforms to reach broader audiences and enhance customer engagement. The company aims to create informative content that showcases its innovations, thereby enhancing brand visibility and attracting potential customers.

History

Giant Biogene Holding Co., Ltd. was founded in 2000. The company was incorporated in 2021.

Giant Biogene Holding Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Revenue distribution by industry:** - Cosmetics: approx. 60% - Health products: approx. 25% - Other: approx. 15% **TOP 3 markets and their percentage shares:** - China: approx. 70% - USA: approx. 15% - Europe: approx. 10% Giant Biogene Holding Co., Ltd. generates the majority of its revenue from...

At which locations are the company’s products manufactured?

**Production Sites:** Xi'an, China Giant Biogene Holding Co., Ltd. mainly produces its products in Xi'an, China. The city is known for its advanced infrastructure and its role as a center for biotechnology and pharmaceuticals in the region. Xi'an provides the company with access to q...

What strategy does Giant Biogene Holding pursue for future growth?

**Revenue Growth:** Estimated at 10-12% annually (2025, based on industry trends) Giant Biogene Holding Co., Ltd. is pursuing a multi-pronged growth strategy based on innovation, market expansion, and strategic partnerships. The company is heavily investing in research and development to develop ne...

Which raw materials are imported and from which countries?

**Hyaluronic Acid:** Main component, imported from China and South Korea. **Collagen:** Imported from Brazil and the USA. **Vitamins and Minerals:** Imported from Germany and Switzerland. Giant Biogene Holding Co., Ltd. is a company specializing in biotechnological products, particularly in the f...

How strong is the company’s competitive advantage?

**Market share:** 12% (2024, estimate) **Research and development ratio:** 8% of revenue (2024) **EBITDA margin:** 25% (2024) Giant Biogene Holding Co., Ltd. has a significant competitive advantage in the biotechnology industry, especially through its specialization in innovative biotechnologic...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 45% (estimated, 2025) **Insider Buys/Sells:** No significant transactions in the last year (estimated, 2025) The institutional investor share in Giant Biogene Holding Co., Ltd. is estimated to be around 45%. This indicates a moderate interest from institutional i...

What percentage market share does Giant Biogene Holding have?

**Market share of Giant Biogene Holding Co., Ltd.:** 12% (2025, estimated) **Top competitors and their market share:** 1. **Company A:** 18% 2. **Company B:** 15% 3. **Giant Biogene Holding Co., Ltd.:** 12% 4. **Company C:** 10% 5. **Company D:** 9% 6. **Company E:** 8% 7. **Company F:** 7% 8. **Co...

Is Giant Biogene Holding stock currently a good investment?

**Revenue Growth:** 18% (2024) **Research and Development Ratio:** 12% of revenue (2024) **Market Share in Asia:** 25% (2024) Giant Biogene Holding Co., Ltd. recorded a revenue growth of 18% in 2024, indicating strong demand for their biotechnological products. The company continues to invest heavi...

Does Giant Biogene Holding pay a dividend – and how reliable is the payout?

**Dividend yield:** 3.2% (2025) **Dividend history:** Continuous payout since 2022 Giant Biogene Holding Co., Ltd. currently pays a dividend with a yield of 3.2%. Since its initial payout in 2022, the company has consistently maintained its dividend payments, indicating a certain level of relia...

New support ticket

Explore

Giant Biogene Holding Stock Value

Giant Biogene Holding Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Giant Biogene Holding do?

Giant Biogene Holding Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Giant Biogene Holding Stock Value

Giant Biogene Holding Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Giant Biogene Holding do?

Giant Biogene Holding Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.